MARKET

REVBU

Revelation Biosciences Inc
REVBU
NASDAQ
Delisted
P/E
P/S
P/B
MARKET CAP
-46000.8696
-
321.89
2,108,480.34
REVELATION BIOSCIENCES - FILES PROSPECTUS TO RESALE 4.72 MLN SHARES OF COMMON STOCK BY SELLING STOCKHOLDERS - SEC FILING
Reuters · 01/30 21:18
Revelation Biosciences Raises $7.3 Million Through Unregistered Warrant Exercise
Reuters · 01/29 11:02
Revelation Biosciences Announces 1-for-4 Reverse Stock Split
Reuters · 01/26 14:55
Revelation Biosciences Raises $11 Million Through Immediate Warrant Exercise
Reuters · 01/26 07:33
Revelation Biosciences Unveils Positive Clinical Data for Gemini in Kidney Disease Treatment
Reuters · 01/14 14:00
Revelation Biosciences Grants 90,000 RSUs to New Employee
Reuters · 01/12 22:00
Revelation Biosciences Prepares Gemini for Late-Stage Acute Kidney Injury Trials
Reuters · 12/03/2025 22:02
Revelation Biosciences Advances Gemini Toward FDA Review for Acute Kidney Injury
Reuters · 11/20/2025 14:00
More

Webull offers Revelation Biosciences Inc stock information, including NASDAQ: REVBU real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, REVBU stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading REVBU stock methods without spending real money on the virtual paper trading platform.